Kernodle & Katon Asset Management Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$239K Buy
3,934
+878
+29% +$53.3K 0.14% 83
2016
Q4
$172K Buy
3,056
+239
+8% +$14K 0.1% 96
2016
Q3
$168K Sell
2,817
-2,158
-43% -$126K 0.1% 99
2016
Q2
$273K Sell
4,975
-138
-3% -$7.34K 0.25% 42
2016
Q1
$258K Buy
5,113
+328
+7% +$16.1K 0.24% 43
2015
Q4
$241K Buy
+4,785
New +$241K 0.23% 24

Other funds holding MRK

Kernodle & Katon Asset Management Group's MRK Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group increased its Merck (MRK) stake by 29% in Q1 2017, buying an estimated $53.3K and bringing the position to 3,934 shares worth $239K. The position accounts for 0.14% of the portfolio, ranked #83.

Kernodle & Katon Asset Management Group first reported a position in MRK in Q4 2015 and has held it in 6 quarters since. The position peaked at $273K in Q2 2016. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • Kernodle & Katon Asset Management Group held 3,934 shares of Merck worth $239K as of Q1 2017.
  • Kernodle & Katon Asset Management Group bought 878 Merck shares in Q1 2017, an estimated $53.3K.
  • Merck made up 0.14% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #83 holding.
  • Kernodle & Katon Asset Management Group first reported a position in Merck in Q4 2015 and has held it in 6 quarters since.
  • Kernodle & Katon Asset Management Group's Merck position peaked at $273K in Q2 2016.
  • 1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.